Cybersecurity and the Future of MedTech

Media Thumbnail
00:00
00:00
1x
  • 0.5
  • 1
  • 1.25
  • 1.5
  • 1.75
  • 2
This is a podcast episode titled, Cybersecurity and the Future of MedTech. The summary for this episode is: <p>The "Consolidated Appropriations Act of 2023" (more commonly referred to as the Omnibus Act) was passed and signed into law on December 29th, 2022. This amendment to the Food and Drug Cosmetic Act has expanded the scope of the FDA beyond just "safety and efficacy" to include the cybersecurity of medical devices. This amendment resembles a watered-down version of the PATCH Act, which failed to pass in late 2022.</p><p>As a result, on March 29, 2023, the FDA gained the legal authority to define and enforce medical device cybersecurity. So for today’s episode, we got THE leading minds in MedTech cybersecurity together to discuss what we need to do next. Chris Gates, Director of Product Security at Velentium, Chris Reed, Vice President of Product Security at Medtronic, and Ken Hoyme, CEO of Dark Star Consulting, join the podcast today to discuss the new guidelines, what the FDA can and can’t say about it, and what kinds of deficiencies you’ll be seeing in the future because of the new legislation.</p><h3>Some of the highlights of this episode include:</h3><ul><li>How the FDA tried to clear a path for routine patches and updates</li><li>The minimum that the omnibus bill is talking about</li><li>No longer needing to make the link between cybersecurity and safety and effectiveness</li><li>When they have the legal authority to enforce cybersecurity</li><li>Why the document took so long to go through</li><li>Security architecture analysis</li><li>Why you should be referencing the April 2022 draft</li><li>Unpatched vulnerabilities at the time of submission</li><li>The effort needed to understand the FDA’s intentions</li></ul><h3>Memorable quotes from this episode:</h3><p><em>“Literally, if you’re not aware of this already, you’re already behind the 8-ball right now and there’s things you’ve got to do.”</em></p><p><em>“Basically, if you think it might be a cyber device, it is a cyber device.”</em></p><p><em>“Don’t sit there and try to be pedantic about this and say “I don’t need to do this because there’s a comma here.” It ain’t gonna work for you.”</em></p><p><em>“A synonym for threat modeling really is security architecture analysis.”</em></p><h3>Links:</h3><p><a href="https://www.linkedin.com/in/christopher-gates-8912a81a/" rel="noopener noreferrer" target="_blank">Christopher Gates</a></p><p><a href="https://www.linkedin.com/in/chrreed/" rel="noopener noreferrer" target="_blank">Chris Reed</a></p><p><a href="https://www.linkedin.com/in/kenhoyme/" rel="noopener noreferrer" target="_blank">Ken Hoyme</a></p><p><a href="https://www.velentium.com/" rel="noopener noreferrer" target="_blank">Velentium</a></p><p><a href="https://www.medtronic.com/us-en/index.html" rel="noopener noreferrer" target="_blank">Medtronic</a></p><p><a href="http://www.darkstar-consulting.com/" rel="noopener noreferrer" target="_blank">DarkStar Consulting</a></p><p><a href="https://blog.greenlight.guru/hubfs/Medical%20Device%20Cybersecurity%20in%202023%20(1).pptx.pdf" rel="noopener noreferrer" target="_blank">Medical Device Cybersecurity in 2023 and Beyond Slides</a></p><p><a href="https://www.linkedin.com/in/etiennenichols/" rel="noopener noreferrer" target="_blank">Etienne Nichols LinkedIn</a></p><p><a href="https://www.greenlight.guru/" rel="noopener noreferrer" target="_blank">Greenlight Guru</a></p><p><br></p>

DESCRIPTION

The "Consolidated Appropriations Act of 2023" (more commonly referred to as the Omnibus Act) was passed and signed into law on December 29th, 2022. This amendment to the Food and Drug Cosmetic Act has expanded the scope of the FDA beyond just "safety and efficacy" to include the cybersecurity of medical devices. This amendment resembles a watered-down version of the PATCH Act, which failed to pass in late 2022.

As a result, on March 29, 2023, the FDA gained the legal authority to define and enforce medical device cybersecurity. So for today’s episode, we got THE leading minds in MedTech cybersecurity together to discuss what we need to do next. Chris Gates, Director of Product Security at Velentium, Chris Reed, Vice President of Product Security at Medtronic, and Ken Hoyme, CEO of Dark Star Consulting, join the podcast today to discuss the new guidelines, what the FDA can and can’t say about it, and what kinds of deficiencies you’ll be seeing in the future because of the new legislation.

Some of the highlights of this episode include:

  • How the FDA tried to clear a path for routine patches and updates
  • The minimum that the omnibus bill is talking about
  • No longer needing to make the link between cybersecurity and safety and effectiveness
  • When they have the legal authority to enforce cybersecurity
  • Why the document took so long to go through
  • Security architecture analysis
  • Why you should be referencing the April 2022 draft
  • Unpatched vulnerabilities at the time of submission
  • The effort needed to understand the FDA’s intentions

Memorable quotes from this episode:

“Literally, if you’re not aware of this already, you’re already behind the 8-ball right now and there’s things you’ve got to do.”

“Basically, if you think it might be a cyber device, it is a cyber device.”

“Don’t sit there and try to be pedantic about this and say “I don’t need to do this because there’s a comma here.” It ain’t gonna work for you.”

“A synonym for threat modeling really is security architecture analysis.”

Links:

Christopher Gates

Chris Reed

Ken Hoyme

Velentium

Medtronic

DarkStar Consulting

Medical Device Cybersecurity in 2023 and Beyond Slides

Etienne Nichols LinkedIn

Greenlight Guru